To further explore whether LINC02167 has a regulatory effect on these cancer-related signaling pathways, we performed Western blot experiments to examine the changes in the levels of key proteins involved in the MAPK, PI3K/AKT, and Wnt signaling pathways after knockdown or overexpression of LINC02167. The gene discussed is AKT1; the disease is cancer.